Issued Patents 2019
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10501458 | Substituted bicyclic fused ring compounds as indoleamine-2,3-dioxygenase inhibitors | Phillip M. Cowley, Alan Wise, Thomas J. Brown, Meredeth A. McGowan, Hua Zhou | 2019-12-10 |
| 10450309 | Aryl sulfonamides as BLT1 antagonists | Satyanarayana Tummanapalli, Phieng Siliphaivanh, Kerrie Spencer | 2019-10-22 |
| 10385038 | Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal | Feng Gong, Xinlu Li, Rui Zhao, Xiquan Zhang, Xinhe Xu +2 more | 2019-08-20 |
| 10370368 | Aryl acylsulfonamides as BLT1 antagonists | Satyanarayana Tummanapalli, Phieng Siliphaivanh, Kerrie Spencer | 2019-08-06 |
| 10336733 | Aryl acylsulfonamides as BLT1 antagonists | Jongwon Lim, Satyanarayana Tummanapalli, Phieng Siliphaivanh, Kerrie Spencer | 2019-07-02 |
| 10336731 | Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitors | Phillip M. Cowley | 2019-07-02 |
| 10329277 | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity | Yan Zhu, Na Zhao, Xianxing Shang, Yuandong Hu, Yong Peng +5 more | 2019-06-25 |
| 10189831 | Non-nucleoside reverse transcriptase inhibitors | Kenneth L. Arrington, Yaozong Li, Yunfu Luo, Mehul Patel | 2019-01-29 |